Clinicopathological Characteristics and Prognostic Significance of RET Fusion in Papillary Thyroid Carcinoma
Head & Neck · 2026-12 · 48 (12) · 3372-3383
DOI: 10.1002/hed.70369 ↗Kurz gefasst
Fachartikel in der Zeitschrift Head & Neck, online erschienen am 25.06.2026. Verfasst von Jiahe Tian und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Head and Neck Surgery, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Y…. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Proto-Oncogene Proteins c-ret, Thyroid Cancer, Papillary. Die Arbeit nennt 36 Literaturangaben.
Abstract (Originalsprache)
Background
To analyze the clinicopathological features and long‐term outcomes of papillary thyroid carcinoma (PTC) patients with rearranged during transfection (RET) proto‐oncogene fusion positive and to explore their genotype–phenotype associations and prognostic significance.
Methods
A retrospective study was conducted on 828 PTC patients treated at Sun Yat‐sen University Cancer Center between January 2018 and December 2020. RET fusions, as well as BRAF and TERT promoter mutations, were primarily detected by quantitative real‐time polymerase chain reaction. Demographic, clinicopathological, and follow‐up data were obtained and analyzed to identify genotype‐specific disease patterns.
Results
RET fusions were identified in 64 patients (7.7%). RET fusion‐positive patients had a significantly greater proportion of pediatric and adolescent onset (12.5% vs. 0.7%; p < 0.001) and had larger tumors (34.4% vs. 10.1%, p < 0.001), higher rates of lateral cervical lymph node metastasis (64.1% vs. 24.6%, p < 0.001), distant metastasis (14.1% vs. 1.0%, p < 0.001), extrathyroidal extension (23.4% vs. 13.9%, p = 0.037), vascular invasion (17.2% vs. 3.9%, p < 0.001), perineural invasion (17.2% vs. 4.6%, p < 0.001), and extranodal extension (34.4% vs. 4.8%, p < 0.001) than their RET fusion‐negative counterparts. The follow‐up data indicated a higher rate of disease progression and poorer clinical outcomes in RET fusion‐positive patients than in RET fusion‐negative patients (21.9% vs. 2.6%, p < 0.001).
Conclusions
RET fusion‐positive PTC is associated with aggressive clinicopathological behavior and poor prognosis. This study highlights the importance of RET fusion testing in PTC for more accurate risk stratification and personalized therapeutic approaches, particularly for high‐risk patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Head and Neck Surgery, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.
- Department of Endoscopy, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.
- Department of Otorhinolaryngology, Ludwigs-Maximilians-University Medical Centre, Munich, Germany.
- Department of Head and Neck Surgery, Sun Yat-sen University Cancer Center Gansu Hospital, Lanzhou, China.
ORCID-Profile: Jiahe Tian, Qiuli Li
Zitieren
APA
Tian, J., Li, Y., Wang, Z., Jiang, K., Hu, A., & Li, Q. (2026). Clinicopathological Characteristics and Prognostic Significance of RET Fusion in Papillary Thyroid Carcinoma. Head & Neck, 48(12), 3372-3383. https://doi.org/10.1002/hed.70369
Vancouver
Tian J, Li Y, Wang Z, Jiang K, Hu A, Li Q. Clinicopathological Characteristics and Prognostic Significance of RET Fusion in Papillary Thyroid Carcinoma. Head & Neck. 2026;48(12):3372-3383. doi:10.1002/hed.70369
BibTeX
@article{Tian2026,
author = {Tian, Jiahe and Li, Yin and Wang, Zhongyu and Jiang, Ke and Hu, Ang and Li, Qiuli},
title = {Clinicopathological Characteristics and Prognostic Significance of RET Fusion in Papillary Thyroid Carcinoma},
journal = {Head & Neck},
year = {2026},
volume = {48},
number = {12},
pages = {3372--3383},
doi = {10.1002/hed.70369}
}
EUVIMED